Bill > S2861

This bill, the Post-Traumatic Stress Disorder Medication Prescribing Improvement Act of 2016, requires the Secretary of Defense to review and monitor how medications are prescribed for post-traumatic stress (PTS) at military treatment facilities, which are healthcare centers run by the Department of Defense. Specifically, within 180 days of the bill becoming law, the Secretary must conduct a thorough review of current prescribing practices for PTS medications, establish a system to track the use of drugs that are not recommended by the VA/DOD Clinical Practice Guideline for Management of Post-Traumatic Stress (a guideline developed by the Department of Veterans Affairs and the Department of Defense), and create a plan to correct any instances where these recommended guidelines are not followed when prescribing these medications. A "pharmaceutical agent" in this context refers to any drug or medication used for treatment, as defined in existing U.S. Code.